Rapport Therapeutics, Inc.
No trades
Fundamentals and stats
The company's current financial position
Total assets for Q3 25 are 535.32 M USD, 87.51% more than in Q2 25. And total liabilities increased by 7.84% in Q3 25 to 23.71 M USD.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Total assets
Total liabilities
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25